GERON CORP Shares Outstanding
GERON CORP (GERN) had Shares Outstanding of 639.86 million shares as of 2025-12-31, per its 10-K filed 2026-03-02.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-03-02
- 2025-12-31: Shares outstanding (split-adjusted) 639.86M shares; Shares authorized (split-adjusted) 1.35B shares.
- 2024-12-31: Shares outstanding (split-adjusted) 606.39M shares; Shares authorized (split-adjusted) 1.35B shares.
- 2023-12-31: Shares outstanding (split-adjusted) 544.91M shares; Shares authorized (split-adjusted) 1.35B shares.
- 2023-05-31: Shares outstanding (split-adjusted) (m); Shares authorized (split-adjusted) 1.35B shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2025-12-31 | 639.86M shares 10-K · filed 2026-03-02 | 1.35B shares 10-K · filed 2026-03-02 |
| 2024-12-31 | 606.39M shares 10-K · filed 2026-03-02 | 1.35B shares 10-K · filed 2026-03-02 |
| 2023-12-31 | 544.91M shares 10-K · filed 2025-02-27 | 1.35B shares 10-K · filed 2025-02-27 |
| 2023-05-31 | (m) | 1.35B shares 10-K · filed 2026-03-02 |
| 2023-04-30 | (m) | 675.00M shares 10-K · filed 2026-03-02 |
| 2022-12-31 | 390.26M shares 10-K · filed 2024-02-28 | 1.35B shares 10-K · filed 2024-02-28 |
| 2021-12-31 | 323.73M shares 10-K · filed 2023-03-16 | 675.00M shares 10-K · filed 2023-03-16 |
| 2021-05-12 | (m) | 1.35B shares 10-K · filed 2025-02-27 |
| 2021-05-11 | (m) | 675.00M shares 10-K · filed 2025-02-27 |
| 2021-05-10 | (m) | 675.00M shares 10-Q · filed 2021-08-16 |
| 2021-05-09 | (m) | 450.00M shares 10-Q · filed 2021-08-16 |
| 2020-12-31 | 310.57M shares 10-K · filed 2022-03-10 | 450.00M shares 10-K · filed 2022-03-10 |
| 2019-12-31 | 199.81M shares 10-K · filed 2021-03-11 | 450.00M shares 10-K · filed 2021-03-11 |
| 2019-06-06 | (m) | 450.00M shares 10-Q · filed 2019-11-06 |
| 2019-06-05 | (m) | 300.00M shares 10-Q · filed 2019-11-06 |
| 2018-12-31 | 186.39M shares 10-K · filed 2020-03-12 | 450.00M shares 10-K · filed 2020-03-12 |
| 2017-12-31 | 159.88M shares 10-K · filed 2019-03-07 | 300.00M shares 10-K · filed 2019-03-07 |
| 2016-12-31 | 159.16M shares 10-K · filed 2018-03-16 | 300.00M shares 10-K · filed 2018-03-16 |
| 2015-12-31 | 158.78M shares 10-K · filed 2017-03-01 | 300.00M shares 10-K · filed 2017-03-01 |
| 2014-12-31 | 157.43M shares 10-K · filed 2016-03-10 | 300.00M shares 10-K · filed 2016-03-10 |
| 2014-05-28 | 156.92M shares 10-Q · filed 2014-08-11 | (m) |
| 2013-12-31 | 130.68M shares 10-K · filed 2015-03-11 | 300.00M shares 10-K · filed 2015-03-11 |
| 2012-12-31 | 130.24M shares 10-K · filed 2014-03-17 | 300.00M shares 10-K · filed 2014-03-17 |
| 2012-05-17 | (m) | 300.00M shares 10-K · filed 2013-03-15 |
| 2011-12-31 | 131.44M shares 10-K · filed 2013-03-15 | 200.00M shares 10-K · filed 2013-03-15 |
| 2010-12-31 | 122.62M shares 10-K · filed 2012-03-07 | 200.00M shares 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |